ConductScience.org, home

Gene · 51744

Papers3,665

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

101 to 120 of 3,665

Download this page as JSON
TitleJournalYearPMIDFound bySource
Identification of immune cells and circulating inflammatory factors associated with neurodevelopmental disorders by bidirectional Mendelian randomization and mediation analysis.Sci Rep202540229469PubTator, text miningPubMed
CD244 Expression by Lymphocytes in Rheumatoid Arthritis With Concomitant Hepatitis C Infection.Int J Rheum Dis202540213953PubTator, text miningPubMed
Metabolic Biomarkers Mediate Allergic Conjunctivitis via Circulating Inflammatory Proteins: Evidence From a Mendelian Randomization Study.Transl Vis Sci Technol202540208894PubTator, text miningPubMed
The causal relationship between circulating inflammatory proteins and heart failure: A two-sample Mendelian randomization study.Medicine (Baltimore)202540184136PubTator, text miningPubMed
Exploring the association between 91 circulating inflammatory proteins and the risk of carcinoid syndrome: a Mendelian randomization analysis.Discov Oncol202540163170PubTator, text miningPubMed
Association of the characteristics of brain magnetic resonance imaging with genes related to disease onset in schizophrenia patients.SLAS Technol202540158807PubTator, text miningPubMed
Adaptive immune responses against common viruses are sustained and functional in end-of-life patients.iScience202540124502PubTator, text miningPubMed
Downregulated STAT3 and STAT5B are prognostic biomarkers for colorectal cancer and are associated with immune infiltration.Discov Oncol202540100436PubTator, text miningPubMed
A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells.J Exp Clin Cancer Res202540045373PubTator, text miningPubMed
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells.J Vis Exp202540029829PubTator, text miningPubMed
Nicotinamide Riboside: A Promising Treatment for Type 1 Cardiorenal Syndrome in Myocardial Infarction-Induced Acute Kidney Injury by Upregulating Nicotinamide Phosphoribosyltransferase-Mediated Nicotinamide Dinucleotide Levels.
J Am Heart Assoc202540008513PubTator, text miningPubMed
Cytotoxic Response of CD4+ T Cells Orchestrated by SLAMF4 in Rheumatoid Arthritis.Arthritis Rheumatol202539895097PubTator, text miningPubMed
Imaging of biphasic signalosomes constructed by checkpoint receptor 2B4 in conventional and chimeric antigen receptor-T cells.iScience202539886466PubTator, text miningPubMed
A large hypothesis-free proteomics study investigating serum inflammatory markers as biomarkers of dry eye disease.Ocul Surf202539884388PubTator, text miningPubMed
Associations between biomarkers of inflammation and depressive symptoms-potential differences between diabetes types and symptom clusters of depression.Transl Psychiatry202539799156PubTator, text miningPubMed
Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease.Br J Haematol202539743683PubTator, text miningPubMed
Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease.J Biol Chem202539662827PubTator, text miningPubMed
Natural Killer Cell-Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell Leukemia.Cancer Immunol Res202539642167PubTator, text miningPubMed
Optimizing the procedure for manufacturing clinical-grade genetically manipulated natural killer cells for adoptive immunotherapy.Cytotherapy202539570247PubTator, text miningPubMed
Human milk feeding practices and serum immune profiles of one-year-old infants in the CHILD birth cohort study.Am J Clin Nutr202539486685PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/51744/papers?page=6